Last reviewed · How we verify

Ibuprofen + Paracetamol — Competitive Intelligence Brief

Ibuprofen + Paracetamol (Ibuprofen + Paracetamol) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Fixed-dose combination of NSAID and analgesic/antipyretic. Area: Pain Management.

marketed Fixed-dose combination of NSAID and analgesic/antipyretic COX-1/COX-2 (ibuprofen); central nervous system analgesic/antipyretic pathways (paracetamol) Pain Management Small molecule Live · refreshed every 30 min

Target snapshot

Ibuprofen + Paracetamol (Ibuprofen + Paracetamol) — Ullevaal University Hospital. Ibuprofen and paracetamol work synergistically to reduce pain and fever through inhibition of prostaglandin synthesis and central nervous system effects.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Ibuprofen + Paracetamol TARGET Ibuprofen + Paracetamol Ullevaal University Hospital marketed Fixed-dose combination of NSAID and analgesic/antipyretic COX-1/COX-2 (ibuprofen); central nervous system analgesic/antipyretic pathways (paracetamol)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Fixed-dose combination of NSAID and analgesic/antipyretic class)

  1. Ullevaal University Hospital · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Ibuprofen + Paracetamol — Competitive Intelligence Brief. https://druglandscape.com/ci/ibuprofen-paracetamol. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: